THERMO FISHER SCIENTIFIC INC.

TMOLast close 654.80 USD · Oct 2, 2026

Machine signal

Active cluster sell — 5 distinct insiders, $61.6M, window ends Aug 31, 2026.

Insider trading at THERMO FISHER SCIENTIFIC INC.

Transactions on record: 6,285; since Jul 28, 2003

Insider buys: 22; $854.3K

Insider sells: 3,142; $2B

Active insiders · 12 months: 20; last filing Sep 29, 2026

Figures computed from official regulatory filings — .

Company financials

Revenue (TTM): 46.3B

EBITDA: 11.7B

EPS (TTM): 18.6

Profit margin: 15.0%

Return on equity: 13.5%

Revenue growth (YoY): 10.5%

P/E ratio: 35.2

Forward P/E: 24.15

Price / sales: 5.23

EV / EBITDA: 23.62

Price / book: 4.67

Dividend yield: 0.3%

52-week range: 434.5–683.63

Analysttarget 652.85 USD (-0%) · consensus 4.46/5 · 23 buy · 4 hold · 1 sell

Ownershipinsiders 0.13% · institutions 94.03% · short 1.4% of float

In USD · as of Oct 5, 2026

Insiders on record at THERMO FISHER SCIENTIFIC INC.

Show all 60 insiders on record

About the company

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Insider	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
BOLT JENNIFER Jtrack record	Sep 29, 2026	AwardD (derivative)	46.3	—	n/a (No price was disclosed in the filing)		SEC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NYSE

Listing on recordSecurity status from the latest source received, not a guarantee of tradability.

Former names

Periods recorded in the consulted sources. These do not certify the legal dates of name changes.

THERMO ELECTRON CORPFeb 18, 1994 / Nov 3, 2006

THERMO FISHER SCIENTIFIC INC.

Insider trading at THERMO FISHER SCIENTIFIC INC.

Company financials

Insiders on record at THERMO FISHER SCIENTIFIC INC.

THERMO FISHER SCIENTIFIC INC.

Insider trading at THERMO FISHER SCIENTIFIC INC.

Company financials

Insiders on record at THERMO FISHER SCIENTIFIC INC.

Insider transaction history at THERMO FISHER SCIENTIFIC INC.

About the company

Insider transaction history at THERMO FISHER SCIENTIFIC INC.